Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
106.96
+0.47 (0.44%)
Nov 5, 2024, 1:19 PM EST - Market open

Vaxcyte Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
-497.19-402.27-223.49-100.08-89.22-50.27
Upgrade
Depreciation & Amortization
1210.179.23.461.411.23
Upgrade
Loss (Gain) From Sale of Assets
--0.040.10.030
Upgrade
Asset Writedown & Restructuring Costs
--0.21-0.27-
Upgrade
Loss (Gain) From Sale of Investments
-37.87-34.78-0.951.41--
Upgrade
Stock-Based Compensation
65.7648.7623.6510.735.431.19
Upgrade
Other Operating Activities
--8-0.18-3.2
Upgrade
Change in Accounts Payable
2.1411.232.9-12.4726.10.87
Upgrade
Change in Other Net Operating Assets
-11.7170.19.84-24.549.173.04
Upgrade
Operating Cash Flow
-466.88-296.79-170.6-121.39-46.63-47.15
Upgrade
Capital Expenditures
-115.46-67.88-5.85-6.56-1.16-1.2
Upgrade
Sale of Property, Plant & Equipment
--0.010.030.05-
Upgrade
Investment in Securities
-407.67-705.4380.43-205.78--
Upgrade
Investing Cash Flow
-523.13-773.3174.59-212.31-1.11-1.2
Upgrade
Long-Term Debt Repaid
-----0.06-0.28
Upgrade
Net Debt Issued (Repaid)
-----0.06-0.28
Upgrade
Issuance of Common Stock
986.66643.69862.4117.8268.450.44
Upgrade
Other Financing Activities
-6.81-3.88-0.86--3.4-1.1
Upgrade
Financing Cash Flow
979.85639.81861.5517.8374.8741.57
Upgrade
Foreign Exchange Rate Adjustments
-1.98-6.690.14-0.440.09-0.34
Upgrade
Net Cash Flow
-12.13-436.97765.67-316.34327.22-7.11
Upgrade
Free Cash Flow
-582.34-364.67-176.45-127.95-47.78-48.34
Upgrade
Free Cash Flow Per Share
-5.38-3.75-2.72-2.46-1.62-12.74
Upgrade
Cash Interest Paid
--00.010.010.04
Upgrade
Levered Free Cash Flow
-382.64-202.41-107.79-88.16-14.4-30.34
Upgrade
Unlevered Free Cash Flow
-382.64-202.41-107.79-88.16-14.39-30.32
Upgrade
Change in Net Working Capital
-15.8-99.06-10.3731-35.91-2.31
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.